Chemosensitivity testing of oral cancer cells treated with a p185neu-specific agent

European Journal of Oral Sciences

Volumn 107, Issue 5, 1999, Pages 338-343

  Werkmeister, R ^a   Fillies, Th ^a   Brandt, B ^a   Groner, B ^b   Wels, W ^b   Joos, U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Chemosensitivity; erbB 2; Oral squamous cell carcinoma; Targeted tumor therapy

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL TOXIN; DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXOTOXIN; IMMUNOTOXIN; LEUCINE; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN; TOXA PROTEIN, PSEUDOMONAS AERUGINOSA; TRITIUM; TUMOR PROTEIN; VIRULENCE FACTOR;

ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG SCREENING; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUMINESCENCE; METABOLISM; MOUTH TUMOR; PROTO ONCOGENE; PSEUDOMONAS AERUGINOSA; SQUAMOUS CELL CARCINOMA;

ADENOSINE TRIPHOSPHATE; ADP RIBOSE TRANSFERASES; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EXOTOXINS; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOTOXINS; LEUCINE; LUMINESCENT MEASUREMENTS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PSEUDOMONAS AERUGINOSA; RADIOPHARMACEUTICALS; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; TRITIUM; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0033208631     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1046/j.0909-8836.1999.eos107504.x     Document Type: Article

References (29)

1. FEARON ER, VOGELSTEIN B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
2. RENAN MJ. How many mutations are required for tumorigenesis? Mol Carcinogen 1993; 7: 139-146.
3. SLAMON DJ, CLARK GM, WONG SG, LEVIN WJ, ULLRICH A, MCGUIRE WL. Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science 1987; 235: 177-182.
4. BRANDT B, VOGT U, SCHLOTTER CM, JACKISCH C, WERKMEISTER R, THOMAS M, VON EIFF M, BOSSE U, ASSMANN G, ZÄNKER KS. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 1995; 159: 35-12.
5. WERKMEISTER R, BRANDT B, VOGT U, JOOS U. Oncogene amplification in oral squamous cell carcinomas (OSCC). Dtsch Z Mund Kiefer GesichtsChir 1995; 19: 118-119.
6. WILKMAN TSE, HIETANEN JHP, MALMSTRÖM MJ, KONTTINEN YT. Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral lesions. Int J Oral Maxillofac Surg 1998; 27: 209-212.
7. KILPI A, RICH AM, KONTTINEN YT, READE PC. Expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus and subsequent squamous cell carcinoma. Eur J Oral Sci 1996; 104: 278-284.
8. KILPI A, RICH AM, KONTTINEN YT, READE PC. The expression of c-erbB-2 protein in keratinocytes of oral mucosal lichen planus. Brit J Dermatol 1995; 133: 847-852.
9. WERKMEISTER R, BRANDT B, JOOS U. Oncogene amplification in oral squamous cell carcinomas. Am J Surg 1996; 172: 681-683.
10. neu protein and the EGF receptor modulates EGF receptor function. Cell 1990; 61: 1339-1347.
11. COUSSENS L, YANG-FENG TL, LIAO YC. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985; 230: 1132-1139.
12. BARGMANN CI, HUNG MC, WEINBERG RA. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986; 45: 649-657.
13. YAMAMOTO T, RIKIMARU N, NOMURA N, ISHIZAKI R, PASTAN I, GAMOU S, SHIMIZU N. High incidence of amplification of the epidermal growth factor receptor gene in human squamous cell carcinomas cell lines. Cancer Res 1989; 46: 414-416.
14. SPURR NK, SOLOMON E, JANSSON M, SHEEN D, GOODFELLOW PN, BODMER WF, VENNSTROM B. Chromosomal localisation of the human homologues to the oncogenes erb-A and B. EMBO J 1984; 3: 159-164.
15. SOLTOFF S, CARRAWAY KL III, PRIGENT SA, GULLICK WG, CANTLEY LC. ErbB3 is involved in activation of phosphatiylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 1994; 14: 3550-3558.
16. erbB4. Nature 1993; 366: 473-475.
17. SLIWKOWSKI MX, SCHAEFER G, AKITA RW, LOFGREN JA, FITZPATRICK VD, NUIJENS A, FENDLY BM, CERIONE RA, VANDLEN RL, CARRAWAY KL III. Coexpression of erBb2 and erbB3 protein s reconstitutes a high-affinity receptor for heregulin. J Biol Chem 1994; 269: 14661-14665.
18. WELS W, HARWERTH IM, ZWICKL M, HARDMANN KD, GRONER B, HYNES N. Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Biotechnology 1992; 10: 1128-1132.
19. WELS W, HARWERTH IM, MÜLLER M, GRONER B, HYNES N. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res 1992; 52: 6310-6317.
20. BRANDT B, VOGT U, HARMS F, BOSSE U, ZÄNKER KS, ASSMANN G. Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content. Gene 1995; 159: 29-34.
21. ROETGER A, BRANDT B, BARNEKOW A. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes. DNA Cell Biol 1997; 16: 443-448.
22. ANDREOTTI PE, CREE IA, KURBACHER CM, HARTMANN DM, LINDER D, HAREL G, GLEIBERMAN I, CARUSO PA, RICKS SH, UNTCH M, SARTORI C, BRUCKNER H. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res 1995; 55: 5276-5282.
23. PLATZ H, FRIES R, HUDEC M. Einführung in die "Prospektive DÖSAK-Studie" über Plattenepithelkarzinome der Lippen, der Mundhöhle und des Oropharynx. Dtsch Z Mund Kiefer GesichtsChir 1988; 12: 293-302.
24. HEMPRICH A, BREIER Th, KOVÁCS G. Langzeitergebnisse der radikalen Therapie von Plattenepithelkarzinomen der Mundhöhle unter besonderer Berücksichtigung von Spätrezidiven und Zweitmalignomen - eine Katamnese aus 20 Jahren, SCHWENZER N. Fortschritte der Kiefer- und Gesichts-Chirugie. Stuttgart: G. Thieme Verlag, 1992; 43-45.
25. erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int J Cancer 1995; 60: 137-144.
26. OGATA M, FRYLING CM, PASTAN I, FITZGERALD DJ. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J Biol Chem 1992; 267: 25396-25401.
27. ULLRICH A, COUSSENS L, HAYFLICK JS, DULL TJ, GRAY A, TAM AW, LEE J, YARDEN Y, LIEBERMANMN JA, SCHLESSINGER J, DOWNWARD J, MAYES ELV, WHITTLE N, WATERFIELD MD, SEEBURG PH. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1994; 309: 418-425.
28. MERLINO GT, XU Y, ISHII S, CLARK AJL, SEMBA K, TOYOSHIMA K, YAMAMOTO T, PASTAN I. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 1984; 224: 417-419.
29. SCHMIDT M, HYNES N, GRONER B, WELS W. A bivalent single-chain antibody-toxin specific for erbB-2 and the EGF receptor. Int J Cancer 1996; 65: 538-546.